Methyl 5-(4-Cyanophenyl)isoxazole-3-carboxylate
≥95%
- Product Code: 81410
CAS:
1375064-41-7
| Molecular Weight: | 228.20 g./mol | Molecular Formula: | C₁₂H₈N₂O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22192328 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, dry |
Product Description:
This compound is primarily utilized in the field of organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of various biologically active molecules, particularly those targeting enzymes or receptors in medicinal chemistry. Its structure, featuring an isoxazole ring and a cyano group, makes it a versatile building block for designing compounds with potential therapeutic applications. Researchers often employ it in the synthesis of novel drug candidates, especially in areas like anti-inflammatory, antimicrobial, or anticancer drug development. Additionally, its unique chemical properties make it suitable for use in the study of structure-activity relationships (SAR) to optimize the efficacy and selectivity of new pharmaceutical agents.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | €137.71 |
+
-
|
| 1.000 | 10-20 days | €306.30 |
+
-
|
Methyl 5-(4-Cyanophenyl)isoxazole-3-carboxylate
This compound is primarily utilized in the field of organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of various biologically active molecules, particularly those targeting enzymes or receptors in medicinal chemistry. Its structure, featuring an isoxazole ring and a cyano group, makes it a versatile building block for designing compounds with potential therapeutic applications. Researchers often employ it in the synthesis of novel drug candidates, especially in areas like anti-inflammatory, antimicrobial, or anticancer drug development. Additionally, its unique chemical properties make it suitable for use in the study of structure-activity relationships (SAR) to optimize the efficacy and selectivity of new pharmaceutical agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :